OnKure Therapeutics, Inc. - OKUR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Apr 01, 2026 | SCHEDULE 13G | ACORN BIOVENTURES, L.P. | 4.5% | 1,854,525 | View |
| Apr 01, 2026 | SCHEDULE 13G | ACORN CAPITAL ADVISORS GP, LLC | 4.5% | 1,854,525 | View |
| Apr 01, 2026 | SCHEDULE 13G | ACORN BIOVENTURES 2, L.P. | 5.0% | 2,069,512 | View |
| Apr 01, 2026 | SCHEDULE 13G | Acorn Capital Advisors GP 2, LLC | 5.0% | 2,069,512 | View |
| Apr 01, 2026 | SCHEDULE 13G | Anders Hove | 9.5% | 3,924,037 | View |
| Feb 17, 2026 | SCHEDULE 13G | ADAR1 Capital Management, LLC | 7.9% | 1,014,158 | View |
| Feb 17, 2026 | SCHEDULE 13G | ADAR1 Capital Management GP, LLC | 6.2% | 793,602 | View |
| Feb 17, 2026 | SCHEDULE 13G | Daniel Schneeberger | 7.9% | 1,014,158 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Highbridge Capital Management, LLC | 4.2% | 542,361 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel Advisors LLC | 0.4% | 48,957 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel Advisors Holdings LP | 0.4% | 48,957 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel GP LLC | 0.4% | 48,957 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel Securities LLC | 1.4% | 174,168 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel Securities Group LP | 1.4% | 174,168 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Citadel Securities GP LLC | 1.4% | 174,168 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Kenneth Griffin | 1.7% | 223,125 | View |
| Jan 30, 2026 | SCHEDULE 13G/A | The Vanguard Group | 4.87% | 626,593 | View |
| Nov 28, 2025 | SCHEDULE 13G | Prosight Management, LP | 5.8% | 745,649 | View |
| Nov 28, 2025 | SCHEDULE 13G | Prosight Fund, LP | 0.3% | 35,514 | View |
| Nov 28, 2025 | SCHEDULE 13G | Prosight Plus Fund, LP | 1.3% | 163,487 | View |
| Nov 28, 2025 | SCHEDULE 13G | Prosight Partners, LLC | 5.8% | 745,649 | View |
| Nov 28, 2025 | SCHEDULE 13G | W. Lawrence Hawkins | 5.8% | 745,649 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.